Menu
Back to Journals » Cancer Management and Research » Volume 12
Original Research
Efficacy and Safety of Nab-Paclitaxel Plus S-1 versus Nab-Paclitaxel Plus Gemcitabine for First-Line Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,974 | Dovepress* | 3,679+ | 570 | 4,249 | |
| PubMed Central* | 295 | 99 | 394 | ||
| Totals | 3,974 | 669 | 4,643 | ||
| *Since 9 December 2020 | |||||
View citations on PubMed Central and Google Scholar